Clinical trial Recruiting at 1 site Interventional Ages 18 to 64 Women only

Preserving muscle during weight loss with incretin therapy

Official title: Resistance Exercise Training to Preserve Muscle Mass and Physical Function During Incretin-Based Weight Loss

Run by Karolinska Institutet · NCT07761923 · Data updated 2026-11-12

This study tests whether unilateral resistance training can help maintain skeletal muscle while women with obesity start incretin-based obesity medicine.

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexWomen only
Enrollment20 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm, Stockholm County)
StatusRecruiting
StartedOctober 27, 2026
Main results expectedDecember 1, 2028
Study endsJanuary 1, 2029
Registry record updatedNovember 3, 2026
Trial IDNCT07761923 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18-64 with BMI ≥35 kg/m² who are starting incretin-based obesity pharmacotherapy and can participate in supervised unilateral resistance training.

Probably not a fit

Patients unable to safely perform resistance training, or those not starting incretin-based therapy, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Women with obesity (BMI ≥35) who are about to begin incretin-based pharmacotherapy will perform supervised unilateral resistance training while receiving treatment. The trial will assess changes in skeletal muscle volume, strength, fatigue, body composition, and cardiac structure and function, alongside molecular profiles in muscle, fat, and blood. It uses a targeted design to see if training protects muscle during drug-induced weight loss and improves overall metabolic health. Outcomes may inform how to combine exercise with incretin therapies in routine care. Imaging and biopsies are used to capture detailed tissue and molecular responses.

Why it matters

Potential benefit: If successful, the approach could help patients lose weight while preserving muscle and maintaining physical function.

How similar studies have gone: Prior research shows resistance training can preserve muscle during weight loss, but this study is among the first to combine it with incretin-based pharmacotherapy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 18-64 years with obesity, BMI ≥35 kg/m²
* Planned initiation of incretin-based obesity pharmacotherapy as part of routine clinical care.
* Able to participate in supervised unilateral resistance training.
* Able to complete physical function tests.
* Able to attend study visits at the study center.
* Able to provide written informed consent in the Swedish language.

Exclusion Criteria:

* Contraindication to magnetic resonance imaging.
* Medical condition preventing resistance training or physical-function testing.
* Medical condition preventing skeletal muscle or adipose-tissue biopsy.
* A weight reduction \>5% during the last 3 months.
* Patients diagnosed with any known serious chronic illness, including type 1 or 2 diabetes (or a randomly measured fasting plasma glucose \>7 mmol/L).
* Angina pectoris, coronary heart disease or congestive heart failure (NYHA Class III- IV).
* Severe renal impairment (creatinine clearance (GFR) \<30 mL/min).
* Severe hepatic impairment.
* Inflammatory bowel disease.
* Gastroparesis.
* Cancer.
* Chronic obstructive lung disease.
* Severe psychiatric disorders.
* Previous bariatric surgery.
* A history of idiopathic acute pancreatitis.
* The use of medications that cause clinically significant weight gain or loss.
* A family or personal history of multiple endocrine neoplasia type 2 or familial medullary thyroid carcinoma.
* Osteoarthritis, which is judged to be too severe to manage the exercise programme.
* Pregnancy, expecting pregnancy or breast feeding.
* Hypersensitivity to the planned incretin-based medication or any of its excipients.
* Regular exercise training at high intensity (eg, spinning) \>2 hours per week.
* Inability to understand the study information in Swedish or provide informed consent.

Where it's running

  • Karolinska University Hospital Huddinge
    Stockholm, Stockholm County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.